HawkScreener
Register Sign In
Dashboard Screener Heatmap Compare Sign In

FTLF

FitLife Brands, Inc. (NASDAQ)

Consumer Defensive — Packaged Foods

FitLife Brands, Inc. provides nutritional supplements and wellness products for health-conscious consumers in the United States and internationally. The company provides weight loss, sports nutrition, and general health products; general wellness products with an emphasis on natural, vegan, and organic ingredients; male health and weight loss products; energy products; general health supplements; and natural skincare and beauty products; supplements focused on targeted nutrition; supplements for weight loss, cleansing and sexual health, and total body wellness. It markets its products under the brand names of NDS Nutrition, PMD Sports, SirenLabs, CoreActive, Nutrology, Metis Nutrition, iSatori, BioGenetic Laboratories, Energize, Dr. Tobias, All-Natural Advice, Maritime Naturals, MusclePharm, Irwin Naturals, Applied Nutrition, and Nature's Secret through franchised stores, as well as through retail locations, which include specialty, mass, and online, and e-commerce platform. The company was formerly known as Bond Laboratories, Inc. and changed its name to FitLife Brands, Inc. in September 2013. FitLife Brands, Inc. was incorporated in 2005 and is headquartered in Omaha, Nebraska.

None 2 analysts
$10.27
$-0.31 (-2.93%)
Target: $17.50 (70.4%)
Sign in to add FTLF to a watchlist or set price alerts.

Price History

52-Week Range

Fundamentals

Market Cap$103.40M
P/E Ratio (TTM)18.35
Forward P/E6.05
EPS (TTM)$0.60
Dividend Yield-
Profit Margin6.64%
Revenue Growth58.90%
ROE14.30%
Debt/Equity93.05
Recommendation None
Analyst Target$17.50
Analysts2
Indexes NASDAQ

Technical Indicators

RSI (14)52.1
Beta0.02
SMA 20-
SMA 40-
52-Week High$20.98
52-Week Low$8.67
50-Day Avg$10.20
200-Day Avg$14.78
Avg Volume32.8K
Volume9.4K

Performance Analysis

BULLISH

FTLF shows predominantly bullish signals based on its fundamentals and technicals.

~ Trading at 13% of its 52-week range.
~ RSI at 52.1 is in neutral territory.
+ Strong revenue growth of 58.9% year-over-year.
~ Wall Street consensus is "none" from 2 analysts.
+ Average analyst target of $17.50 implies 70.4% upside.

Recent News

Loading news...
Sign in for full analysis Unlock insider trading data, options chain, news feed, and more.
Sign In

Last updated: Jul 02, 2026 13:10 UTC

Back to Screener Export Report